• Mashup Score: 33

    Nature Immunology – Here the authors identify the granin hormone SCG2 as a ligand for the inhibitory receptor LILRB4. They show that SCG2 released from tumors can suppress antitumor immune…

    Tweet Tweets with this article
    • A hormone binding to the LILRB4 receptor on #ImmuneCells suppresses their tumor-fighting function, enabling #Cancer to evade detection and suggesting new targets for immunotherapy and inflammatory disease treatment. @UTSWNews @natimmunol https://t.co/Ut2P7V8l8U

  • Mashup Score: 74

    The recognition of intracellular antigens by CD8+ T cells through T cell receptors (TCRs) is central for adaptive immunity against infections and cancer. However, the identification of TCRs from patient material remains complex. We present a rapid de …

    Tweet Tweets with this article
    • An AI platform now enables rapid design of protein binders that reprogram #ImmuneCells to target #Cancer, potentially accelerating personalized immunotherapy development from years to weeks. @sciencemagazine https://t.co/5Bh4Yoc27o https://t.co/jyISvWWNnI